Want to join the conversation?
$GIII expects 3Q17 net sales of about $940MM, net income of $70-76MM and EPS of $1.50-1.60. The 3Q forecast does not reflect any additional expenses related to pending acquisition that may be incurred in 3Q17. The company predicts non-GAAP EPS of $1.85 for 3Q17.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?